In the News | Week of 2.4.2019

In the News highlights key news stories from the prior quarter for companies announcing earnings over the next week, or for other major economic announcements. These stories are not the most read or the most important, but they are the most representative of the stories that mention these companies and events.

The Clorox Company (CLX)

Clorox As A Defensive Stock Looks Solid And Accordingly Priced

How d-to-c is changing the way brands are built

Clorox Implements A Practical Approach To Value Chain Segmentation

Gilead Sciences (GILD)

2018 New Drugs Approvals: An All-Time Record, And A Watershed

The $35 billion race to cure a silent killer that affects 30 million Americans

Did Gilead Sciences Make an $11 Billion Blunder?

Alphabet, Inc. (GOOG/GOOGL)

The Areas Where Google and Amazon Outperform Each Other in Voice Technology

Google DeepMind Looks To Boost Oxford’s Diversity With New Scholarships

Google news app warning

Tech Giants Seize TV’s Biggest Stage, After Shunning Mass-Market Ads

Alphabet Can Be Bought as It Survives Third Dip Into Bear Market

Sysco Corporation (SYY)

Amazon Is Expanding Whole Foods. Will Amazon Acquire A Grocery Distributor As Well?

BRIEFS; Sysco to buy Waugh in food merger

Food Distributors Make Changes as Costs Bite

Archer Daniels Midland (ADM)

Ethanol Falls To A Record Low

Flotek Sells Once-Maligned Citrus Flavors Unit

ADM Recognized for Outstanding Sustainability Leadership

Allstate (ALL)

Allstate Is Now A Data And Technology Company – My CES Interview With CEO Tom Wilson

Wildfires Could Cost Insurers $5 Billion To $10 Billion: Credit Suisse Analysts

Chubb (CB)

California wildfires-related insured losses within anticipated level: Fitch

3 Reasons Why We Expect the D&O Market to Harden

Chubb European Group Completes Redomicile to France in Preparation for Brexit

Walt Disney (DIS)

Box Office: ‘Mary Poppins Returns’ Highlights Disney’s Reliance On Superheroes

Is Disneyland repeating Apple’s mistake?

Netflix’s price hike: How much is too much for consumers?

Electronic Arts (EA)

CMOs Can Learn How to Be More Progressive and Innovative From Gaming Brands

EA Reportedly Releasing Titan-Free ‘Titanfall’ Battle Royale Game ‘Apex Legends’ On Monday

Call Of Duty: Black Ops 4’s Microtransactions Are Terrible, But Do They Ruin The Game?

Estee Lauder (EL)

Deciem Founder Brandon Truaxe Has Died

Why Innovative Hair Care Brand Hairstory Says ‘No’ To Shampoo And To Selling At Ulta And Sephora

Marcia Kilgore, Founder Of Beauty Pie, On Disrupting Everyone From Estee Lauder To Glossier

Emerson Electric (EMR)

CEOs Work to Figure Out Trump — Journal Report

Investors Punish U.S. Companies Vulnerable to China’s Slowdown

Vertex Pharmaceuticals (VRTX)

Moderna Raises $604 Million in Year’s Biggest Biotech IPO

CRISPR Therapeutics Is Dead Money For Years To Come

Vertex Pharma’s VX-150 successful in mid-stage neuropathy study

Boston Scientific (BSX)

Boston Scientific Corporation (BSX) CEO Mike Mahoney presents at 37th Annual J.P. Morgan Healthcare Conference (Transcript)

After a Teenage Cancer Scare, She Invented an Early-Detection Device at 24. She Sold Her Company for $275 Million 9 Years Later

The First Frontier for Medical AI Is the Pathology Lab

Twenty-first Century Fox (FOX / FOXA)

Here’s Why Netflix’s Subscriber Count Is Soaring

Fox Said to Borrow $6.8 Billion for Disney-Related Dividend

After Netflix’s Price Hikes, Hulu Heads the Other Way

General Motors (GM)

GM CEO Barra, Larry Kudlow to meet after layoffs announcement

GM workers will have job options – but they may not be as good

General Motors to discontinue Chevy Impala amid plant closures

General Motors News From Ohio, Michigan Could Hurt Trump 2020 Bid

Humana (HUM)

UPDATE 1-Aetna, other health insurers team up with IBM on blockchain project

Walgreens lays out plan to save $1 billion a year

Aetna, Ascension Join Healthcare Blockchain Alliance To Check Data Quality

Eli Lilly (LLY)

Two Big Pharma Stocks Were Dow’s Best, but 2019 Looks Shakier

Pfizer and Lilly’s tanezumab successful in second late-stage study

Pfizer and the Urge to Merge

O’Reilly Automotive (ORLY)

No connected articles of note.

Prudential Financial (PRU)

Long-Term Care Insurance Policies Weigh Down GE and Other Companies

Prudential Financial, Inc. (PRU) Management Presents 2019 Financial Outlook Conference Call (Transcript)

Regeneron Pharmaceuticals (REGN)

Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals

Health Investors Get Selective as Markets Churn Into 2019

Pitfalls in the measurement of muscle mass: a need for a reference standard

Fiserv (FISV)

Fiserv to Combine with First Data Corporation to Create Global Leader in Payments and FinTech

A $22 Billion Fintech Tie-Up Aims at Square

Payment Stocks Are Poised for a Sunny 2019

Marathon Petroleum (MPC)

Deepwater Rivalry: Competing offshore crude oil export terminals proposed near Houston

Venezuelan Oil Loses Two U.S. Buyers in 2018 Amid Sanctions

These are the 10 biggest mergers of the year

Philip Morris International (PM)

FDA Moves to Restrict Flavored E-Cig Sales, Ban Menthol Cigarettes

Marlboro Parent Company Looking to Stop Cigarette Production Forever in Favor of Smoke-free Products

Yum Brands (YUM)

Taco Bell is ‘dialing up’ spice levels of their sauces for new restaurants

Junk Food Companies Spend Billions Of Dollars On Ads Targeting Black Children

Supermarkets Warn Government of Empty Shelves in No-Deal Brexit

Exelon Corp (EXC)

Alzheimer’s Treatment (Ed Note: This isn’t about Exelon Corp. But I’m including it as a reminder that computers are still very often in need of supervision. )

Let Exelon Haggle With Your Car Dealer (Ed Note: And this one actually is!)

Exelon Keeps Mid-Atlantic And Chicago Warm And Wired

Environmentalists Warm to Nuclear Amid Climate Change Threat

Phillips 66 (PSX)

Crude spirals to 17-month low amid global economic concerns

Need More Cash Flow And Less Risk? Try These 7% Trades

Phillips 66: Reloading The Growth Pipeline In 2019

Phillips 66 to pour billions in new capital projects next year

To learn more about Epsilon Theory and be notified when we release new content sign up here. You’ll receive an email every week and your information will never be shared with anyone else.

Start the discussion at the Epsilon Theory Forum

The Latest From Epsilon Theory


This commentary is being provided to you as general information only and should not be taken as investment advice. The opinions expressed in these materials represent the personal views of the author(s). It is not investment research or a research recommendation, as it does not constitute substantive research or analysis. Any action that you take as a result of information contained in this document is ultimately your responsibility. Epsilon Theory will not accept liability for any loss or damage, including without limitation to any loss of profit, which may arise directly or indirectly from use of or reliance on such information. Consult your investment advisor before making any investment decisions. It must be noted, that no one can accurately predict the future of the market with certainty or guarantee future investment performance. Past performance is not a guarantee of future results.

Statements in this communication are forward-looking statements. The forward-looking statements and other views expressed herein are as of the date of this publication. Actual future results or occurrences may differ significantly from those anticipated in any forward-looking statements, and there is no guarantee that any predictions will come to pass. The views expressed herein are subject to change at any time, due to numerous market and other factors. Epsilon Theory disclaims any obligation to update publicly or revise any forward-looking statements or views expressed herein. This information is neither an offer to sell nor a solicitation of any offer to buy any securities. This commentary has been prepared without regard to the individual financial circumstances and objectives of persons who receive it. Epsilon Theory recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial advisor. The appropriateness of a particular investment or strategy will depend on an investor’s individual circumstances and objectives.